儿童与成人脑蛛网膜囊肿手术治疗策略及结局评估
该单中心回顾性研究纳入2000至2022年收治的62例新诊断脑蛛网膜囊肿手术患者,比较显微/内镜手术与立体定向分流置入术的疗效。结果显示两种术式临床改善和囊肿体积缩小程度相当,复发率16.1%且与术式无关;术前脑室扩大、瘫痪及年龄小于6岁为复发独立危险因素。婴幼儿后颅窝显微手术可能伴严重静脉出血风险。
要点
- 显微/内镜手术与立体定向分流置入术在症状改善和囊肿体积缩小上效果相当,复发率无差异(p=0.7)。
- 术前脑室扩大(p=0.03)、瘫痪(p=0.008)和年龄小于6岁(p=0.03)是囊肿复发的独立危险因素。
- 婴幼儿复杂囊肿桥前池开窗术中可出现致命性静脉出血并发症。
核心结论
- 显微/内镜手术和立体定向分流置入术均可改善脑蛛网膜囊肿患者临床症状且手术风险低,囊肿体积缩小程度相当。
- 婴幼儿和低龄儿童脑蛛网膜囊肿常伴严重临床症状,立体定向手术应用受限,后颅窝显微手术可能伴严重静脉出血风险。
研究设计与样本
- 单中心回顾性数据库研究,纳入2000年至2022年期间新诊断并接受手术治疗的脑蛛网膜囊肿患者62例,中位年龄26.5岁(范围0-82岁),分为小于6岁组15例、6-18岁组10例、18岁及以上组37例。
- 显微/内镜手术以安全囊肿壁开窗为目标,立体定向分流管置入术用于3岁及以上患者,治疗决策由跨学科共识做出。
- 主要终点为囊肿复发时间,次要终点包括临床症状和磁共振形态学分析。
主要发现
- 35例接受显微/内镜手术,27例接受立体定向分流置入术,各年龄组间手术方式频率无差异。
- 婴儿(4月龄和10月龄)复杂囊肿桥前池开窗尝试中出现2例(22.2%)围手术期静脉并发症,其中10月龄男婴死亡。
- 其他并发症包括术后出血2例(22.2%)、脑脊液漏4例(44.4%)、脑膜炎1例(11.1%)。
- 所有其他患者均见临床改善和显著囊肿体积缩小(p=0.008),各年龄组间无差异;中位随访25.4个月(范围3.1-87.1个月),复发率16.1%,与手术方式无关(p=0.7),复发者囊肿复发时间7.9±12.7个月。
- 多因素分析显示术前脑室扩大(p=0.03)、瘫痪(p=0.008)和年龄小于6岁(p=0.03)为囊肿复发显著危险因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The best treatment strategies for cerebral arachnoid cysts (CAC) are still up for debate. In this study, we present CAC management, outcome data, and risk factors for recurrence after surgical treatment, focusing on microscopic/endoscopic approaches as compared to minimally invasive stereotactic procedures in children and adults. METHODS: In our single-institution retrospective database, we identified all patients treated surgically for newly diagnosed CAC between 2000 and 2022. Microscopic/endoscopic surgery (ME) aimed for safe cyst wall fenestration. Stereotactic implantation of an internal shunt catheter (STX) to drain CAC into the ventricles and/or cisterns was used as an alternative procedure in patients aged ≥ 3 years. Treatment decisions in favor of ME vs. STX were made by interdisciplinary consensus. The primary study endpoint was time to CAC recurrence (TTR). Secondary endpoints were outcome metrics including clinical symptoms and MR-morphological analyses. Data analysis included subdivision of the total cohort into three distinct age groups (AG1, < 6 years; AG2, 6-18 years; AG3, ≥ 18 years). RESULTS: Sixty-two patients (median age 26.5 years, range 0-82 years) were analyzed. AG1 included 15, AG2 10, and AG3 37 patients, respectively. The main presenting symptoms were headache and vertigo. In AG1 hygromas, an increase in head circumference and thinning of cranial calvaria were most frequent. Thirty-five patients underwent ME and 27 STX, respectively; frequency did not differ between AGs. There were two (22.2%) periprocedural venous complications in infants (4- and 10-month-old) during an attempt at prepontine fenestration of a complex CAC, one with fatal outcome in a 10-month-old boy. Other complications included postoperative bleeding (2, 22.2%), CSF leaks (4, 44.4%), and meningitis (1, 11.1%). Overall, clinical improvement and significant volume reduction (p = 0.008) were seen in all other patients; this did not differ between AGs. Median follow-up for all patients was 25.4 months (range, 3.1-87.1 months). Recurrent cysts were seen in 16.1%, independent of surgical procedure used (p = 0.7). In cases of recurrence, TTR was 7.9 ± 12.7 months. Preoperative ventricular expansion (p = 0.03), paresis (p = 0.008), and age under 6 years (p = 0.03) were significant risk factors for CAC recurrence in multivariate analysis. CONCLUSIONS: In patients suffering from CAC, both ME and STX can improve clinical symptoms at low procedural risk, with equal extent of CAC volume reduction. However, in infants and young children, CAC are more often associated with severe clinical symptoms, stereotactic procedures have limited use, and microsurgery in the posterior fossa may bear the risk of severe venous bleeding.
引用
- Schmutzer-Sondergeld M, Gencer A, Niedermeyer S, et al. Evaluation of surgical treatment strategies and outcome for cerebral arachnoid cysts in children and adults. Acta Neurochir (Wien). 2024. PMID: 38280116. doi:10.1007/s00701-024-05950-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。